Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-038007

President and CEO sold 3,745 shares at $0.98 ($3,655)

  • President and CEO acquired 10,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shukla Sanjay · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +10,375 157,298 D
2026-02-04 Sale : show line 2 in the form −3,745 $0.98 $3,655 153,553 D
Open-market sales · 3,745 sh · avg $0.98 · $3,655

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Unit −10,375 0 D
Loading xslF345X05/ownership.xml…